Stösser Sebastian, Isakeit Julia, Bode Felix J, Bode Christian, Petzold Gabor C
Division of Vascular Neurology, Department of Neurology, University Hospital Bonn, Bonn, Germany.
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Front Neurol. 2022 Jul 12;13:902809. doi: 10.3389/fneur.2022.902809. eCollection 2022.
Infections are an important complication after stroke and negatively affect clinical outcome. While pneumonia and urinary tract infections are well recognized after stroke, the incidence and consequences of sepsis remain unclear. The aim of this study was to evaluate the frequency and characteristics of sepsis in patients undergoing endovascular therapy for large vessel occlusion stroke, and its association with clinical outcome.
We analyzed a cohort of patients who underwent endovascular therapy at a single center between 2016 and 2020. The diagnosis and timing of infections and Sequential Organ Failure Assessment scores were evaluated retrospectively to identify patients with sepsis. Patients with sepsis were compared to controls regarding clinical characteristics and outcome.
Fifty-four of 406 patients (13.3%) were found to have sepsis. The median onset of sepsis was 2 days after admission. The majority of cases (85.2%) was caused by pneumonia. At 3 months, 72.5% of patients with sepsis were bedridden or dead compared to 25.7 and 42.7% of controls and patients with an infection without sepsis, respectively. The adjusted odds ratio (95% confidence interval) for a poor outcome was 5.4 (1.6-17.6) for patients with sepsis vs. controls, and 2.0 (0.8-5.2) for patients with sepsis vs. patients with an infection without sepsis.
Sepsis is a frequent complication after large vessel occlusion stroke, and may be associated with a poor clinical outcome. More studies are needed to determine specific risk factors and measures to early recognize and reduce the possibly negative impact of sepsis on outcome after stroke.
感染是卒中后的一种重要并发症,对临床结局有负面影响。虽然卒中后肺炎和尿路感染已得到充分认识,但脓毒症的发生率和后果仍不明确。本研究的目的是评估大血管闭塞性卒中接受血管内治疗患者的脓毒症发生率和特征,及其与临床结局的关系。
我们分析了2016年至2020年在单一中心接受血管内治疗的一组患者。回顾性评估感染的诊断和时间以及序贯器官衰竭评估评分,以确定脓毒症患者。将脓毒症患者与对照组在临床特征和结局方面进行比较。
406例患者中有54例(13.3%)被发现患有脓毒症。脓毒症的中位发病时间为入院后2天。大多数病例(85.2%)由肺炎引起。在3个月时,脓毒症患者中有72.5%卧床或死亡,而对照组和无脓毒症感染患者的这一比例分别为25.7%和42.7%。脓毒症患者与对照组相比,不良结局的调整优势比(95%置信区间)为5.4(1.6 - 17.6),脓毒症患者与无脓毒症感染患者相比为2.0(0.8 - 5.2)。
脓毒症是大血管闭塞性卒中后的常见并发症,可能与不良临床结局相关。需要更多研究来确定特定风险因素以及早期识别和减少脓毒症对卒中后结局可能产生的负面影响的措施。